ARCHIVES

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

This article is from The Cancer Letter archive.

Vol. 29 No. 18 | May 2, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Emory’s Winship Cancer Institute Wins NCI Cancer Center Designation

April 17, 2009

House Panel Targets AWP For Medicare Drug Pricing.

October 5, 2001

Advisors Say 10 Percent Payline “Not Tenable;” All NCI Programs Must Share Budget Cuts.

March 31, 2006

Bonadonna, Fisher Share %50,000 Bristol-Myers Award

April 23, 1993

Carter In Last Budget Asks Four Percent Increase For NCI, But Then Seeks $13.5 Million Rescission

January 23, 1981